Correlation Between Radcom and ATyr Pharma,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Radcom and ATyr Pharma, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Radcom and ATyr Pharma, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Radcom and aTyr Pharma,, you can compare the effects of market volatilities on Radcom and ATyr Pharma, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Radcom with a short position of ATyr Pharma,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Radcom and ATyr Pharma,.

Diversification Opportunities for Radcom and ATyr Pharma,

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Radcom and ATyr is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Radcom and aTyr Pharma, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on aTyr Pharma, and Radcom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Radcom are associated (or correlated) with ATyr Pharma,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of aTyr Pharma, has no effect on the direction of Radcom i.e., Radcom and ATyr Pharma, go up and down completely randomly.

Pair Corralation between Radcom and ATyr Pharma,

Given the investment horizon of 90 days Radcom is expected to generate 1.27 times less return on investment than ATyr Pharma,. But when comparing it to its historical volatility, Radcom is 1.07 times less risky than ATyr Pharma,. It trades about 0.16 of its potential returns per unit of risk. aTyr Pharma, is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest  304.00  in aTyr Pharma, on September 2, 2024 and sell it today you would earn a total of  49.00  from holding aTyr Pharma, or generate 16.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Radcom  vs.  aTyr Pharma,

 Performance 
       Timeline  
Radcom 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Radcom are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, Radcom displayed solid returns over the last few months and may actually be approaching a breakup point.
aTyr Pharma, 

Risk-Adjusted Performance

19 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in aTyr Pharma, are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, ATyr Pharma, reported solid returns over the last few months and may actually be approaching a breakup point.

Radcom and ATyr Pharma, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Radcom and ATyr Pharma,

The main advantage of trading using opposite Radcom and ATyr Pharma, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Radcom position performs unexpectedly, ATyr Pharma, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma, will offset losses from the drop in ATyr Pharma,'s long position.
The idea behind Radcom and aTyr Pharma, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance